ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jun 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
July 2026
Nuclear Technology
June 2026
Fusion Science and Technology
May 2026
Latest News
North American construction is back—smaller and faster—at OPG’s Darlington
“The nuclear renaissance is real here,” said Ontario Power Generation’s Subo Sinnathamby on May 8, one year to the day after OPG secured a final investment decision to build the first of four planned BWRX-300 reactors at its Darlington nuclear power plant, and shortly after the new reactor’s foundation was lifted into place. “We got our license to construct in April and our [final investment decision] in May, and we’ve been off to the races since.”
Steven J. Stanley, Kat Lennox, Alex Jenkins
Nuclear Technology | Volume 183 | Number 2 | August 2013 | Pages 260-269
Technical Paper | Radiation Measurements and General Instrumentation | doi.org/10.13182/NT12-141
Articles are hosted by Taylor and Francis Online.
The RadBall is a 140-mm (5.5-in.)-diam deployable, passive, nonelectrical gamma hot-spot imaging device that offers a 360-deg view of the deployment area. The device is particularly useful in instances where the radiation fields inside a nuclear facility are unknown, but a suitable decommissioning strategy is required to be planned. The original version of the technology had a number of drawbacks including a relative insensitivity to radiation (at least 3 Gy required), which led to long deployment times, as well as a narrow target dose range (3 to 8 Gy), which meant that the user required prior knowledge of the radiation fields in which the device was to be deployed. The United Kingdom's National Nuclear Laboratory has developed the technology to overcome both of these issues. The developments associated with the new technology are described here, as are some recent tests undertaken at the Sellafield facility in the United Kingdom. The work has resulted in a significant improvement in sensitivity - 150 times - as well as greatly widened the target dose range to between 20 mGy and 50 Gy. The new version of the technology therefore has a much-improved applicability compared to the original technology.